Does anyone have experience with Cyltezo, a biosimilar of Humira, since my rheumatologist wants me to start it?
Cyltezo is the first FDA-approved interchangeable biosimilar to Humira for treating psoriasis and psoriatic arthritis. This means it's been proven to work the same way as Humira through rigorous testing and Show Full Answer
Does anyone have experience with Cyltezo, a biosimilar of Humira, since my rheumatologist wants me to start it?
Cyltezo is the first FDA-approved interchangeable biosimilar to Humira for treating psoriasis and psoriatic arthritis. This means it's been proven to work the same way as Humira through rigorous testing and clinical trials.
In studies comparing Cyltezo to Humira, researchers found no differences in safety, effectiveness, or how the body responds to the medication. Both medications carry the same potential side effects, including the risk of serious infections.
The main advantages of Cyltezo include:
* Lower cost compared to Humira
* Can be substituted by pharmacists without a new prescription
* Same dosing and administration (subcutaneous injection)
Research on a similar adalimumab biosimilar showed that about 74% of people continued treatment after one year, with lack of effectiveness and side effects being the most common reasons for stopping (usually within the first year).
Your rheumatologist likely recommends this because it offers the same therapeutic benefits as Humira while potentially reducing your out-of-pocket costs. Since you're managing psoriatic arthritis, this could help control both joint inflammation and any skin symptoms.
November 22, 2025
Join
Your Privacy Choices
